6301:TSEKomatsu Ltd. Analysis
Data as of 2026-05-24 - not real-time
MX$725.44
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Komatsu Ltd. is trading at the identified support level with an **RSI of under 4**, signaling extreme oversold conditions and a potential short‑term rebound. The price sits below the 20‑day and 50‑day SMAs, while the 200‑day SMA is roughly aligned with current levels, suggesting the stock is near a longer‑term equilibrium. A bearish MACD histogram and decreasing volume add pressure, but the extreme momentum reading and strong dividend yield of nearly 3% provide a cushion for risk‑averse traders.
Fundamentally, the company’s **PE of 16** is well under the industry average of nearly 30, indicating an undervalued valuation. Operating margins above 12% and a payout ratio under 50% point to sustainable earnings and dividend capacity. Low computed beta and a solid cash position offset the high 30‑day volatility, making Komatsu a compelling candidate for value‑oriented investors with a medium‑term horizon.
Fundamentally, the company’s **PE of 16** is well under the industry average of nearly 30, indicating an undervalued valuation. Operating margins above 12% and a payout ratio under 50% point to sustainable earnings and dividend capacity. Low computed beta and a solid cash position offset the high 30‑day volatility, making Komatsu a compelling candidate for value‑oriented investors with a medium‑term horizon.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- RSI in extreme oversold territory
- Price at identified support level
- Attractive dividend yield
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Undervalued PE relative to peers
- Stable operating margins and cash flow
- Cyclical exposure in construction equipment
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Sustainable dividend payout
- Long‑term undervaluation with solid fundamentals
- Low market beta despite high short‑term volatility
Key Metrics & Analysis
Financial Health
Revenue Growth6.10%
Profit Margin9.11%
P/E Ratio16.1
ROE11.39%
ROA5.81%
Debt/Equity38.28
P/B Ratio1.7
Op. Cash FlowMX$449.0B
Free Cash FlowMX$13.5B
Industry P/E29.7
Technical Analysis
TrendNeutral
RSI3.9
SupportMX$725.44
ResistanceMX$847.74
MA 20MX$774.36
MA 50MX$818.39
MA 200MX$724.06
MACDBearish
VolumeDecreasing
Fear & Greed Index91.61
Valuation
GradeUndervalued
TypeBlend
Dividend Yield2.86%
Risk Assessment
Beta0.23
Volatility45.15%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.